USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Chinese Pharmaceutical Market
Chinese Pharmaceutical Market
RELEASE DATE
09-May-2013
09-May-2013
REGION
Asia Pacific
Asia Pacific
Research Code: P704-01-00-00-00
SKU: LS00139-AP-MR_16980
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
LS00139-AP-MR_16980
Description
The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the market challenges and opportunities, competitive analysis, offers a revenue forecast, and a list of local company profiles along with their revenue.
Table of Contents
Executive Summary
Executive Summary—Market Engineering Measurements
Executive Summary—CEO’s Perspective
Market Overview—Segmentation
Market Overview—Key Questions This Study Will Answer
Global Top 10 Pharmaceutical Markets
Market Engineering Measurements
Chinese Pharmaceutical Market—Revenue Forecast
Revenue Forecast Discussion
Market Overview of Chinese Pharmaceutical Market—Financial Status
Market Challenges and Opportunities—Key Challenges for Chinese Pharmaceutical Manufacturers
Market Challenges and Opportunities—Internal Challenges for Pharmaceutical Manufacturers Discussion
Industry Challenges and Opportunities—External Challenges for Pharmaceutical Manufacturers Discussion
Market Challenges and Opportunities—Growth Opportunities for Pharmaceutical Manufacturers
Distribution Trends and Analysis—Pharmaceutical Distribution Integration Forecast
Distribution Trends and Analysis—Pharmaceutical Distribution Integration Forecast Discussion
Distribution Trends and Analysis—Pharmaceutical Supply Forecast Discussion
Competitive Analysis
Competitive Analysis (continued)
Competitive Analysis (continued)
Top Chinese Pharmaceutical Industry Participants
Top Chinese Pharmaceutical Industry Participants (continued)
Company Profile—Guangzhou Pharmaceutical Holdings Ltd.
Company Profile—Xiuzheng Pharmaceutical Group Co., Ltd.
Company Profile—Yangtze River Pharmaceutical Group
Company Profile—Harbin Pharmaceutical Group Holding Co., Ltd.
Company Profile—Shanghai Pharmaceutical Holding Co., Ltd.
Company Profile—China Shijiazhuang Pharmaceutical Group Co., Ltd.
Company Profile—North China Pharmaceutical Group Corporation
Company Profile—China National Pharmaceutical Group Corporation
Company Profile—China National Pharmaceutical Group Corporation (continued)
Company Profile—Northeast Pharmaceutical Group Co. Ltd.
Company Profile—China Resources Double-crane Pharmaceutical Co., Ltd.
Company Profile—Hangzhou East China Pharmaceutical Group Co., Ltd.
Company Profile—Kelun Pharmaceutical Co., Ltd.
Company Profile—Heilongjiang Zhenbao Island Pharmaceutical Co., Ltd.
Company Profile—Kangmei Pharmaceutical Co., Ltd.
Company Profile—Qilu Pharmaceutical Co., Ltd.
Company Profile—Furen Medicine Group Ltd.
Company Profile—Shanghai Fosun Pharmaceutical (Group) Ltd.
Company Profile—China Resources Three Nine Pharmaceutical Co., Ltd.
Company Profile—Reyoung Pharmaceutical Co., Ltd.
Company Profile—Jiangxi Jimin Kexin Pharmaceutical Co., Ltd
Company Profile—Jiangsu Heng Rui Medicine Co., Ltd.
Company Profile—Yunnan Baiyao Group Co., Ltd.
Company Profile—Luye Pharma Group Ltd.
Company Profile—Tianjin Zhongxin Pharmaceutical Group Co., Ltd.
Company Profile—Jiangsu Hansoh Pharmaceutical Co., Ltd.
Company Profile—Heze Ruiying Pharmaceutical Group Co., Ltd.
Company Profile—Zhuhai United Laboratories Pharmaceutical Co., Ltd.
Company Profile—Zhejiang NHU Group Holdings Ltd.
Company Profile—Taiji Group Holdings Ltd.
Company Profile—Lunan Pharmaceutical Group Co., Ltd.
Company Profile—Shandong Luoxin Pharmacy Stock Co., Ltd.
Company Profile—Shandong Luoxin Pharmacy Stock Co., Ltd. (continued)
Company Profile—Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.
Company Profile—Renhe (Group) Development Co., Ltd.
Company Profile—Zhejiang Medicine Co., Ltd.
Company Profile—Wuhan Humanwell Healthcare(Group) Co., Ltd.
Company Profile—Nanjing Pharmaceutical Industry (Group) Co., Ltd.
Conclusions and Recommendations—Game Changing Strategies
Conclusions and Recommendations—Conclusions
Conclusions and Recommendations—Recommendations
Legal Disclaimer
Table of Acronyms Used
Exchange Rate in the Study
Who is Frost & Sullivan
What Makes Us Unique
TEAM Methodology
Our Global Footprint 40+ Offices
Popular Topics
The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the market challenges and opportunities, competitive analysis, offers a revenue forecast, and a list of local company profiles along with their revenue.
| No Index | Yes |
|---|---|
| Podcast | No |
| WIP Number | P704-01-00-00-00 |
| Is Prebook | No |